#comparison
3 articles tagged with #comparison
Tirzepatide vs Semaglutide — Dual vs Single Incretin Research
Tirzepatide and Semaglutide are the two most-studied incretin research peptides, but they target different receptor profiles. This head-to-head explains what GIP-receptor activation adds to a GLP-1 base, why Tirzepatide is GIP-biased, and how the two compounds compare in research applications.
GLP-1 Incretin Research — Semaglutide, Tirzepatide, Retatrutide Compared
A receptor-pharmacology comparison of the three flagship incretin research peptides: Semaglutide (single GLP-1 agonist), Tirzepatide (dual GIP/GLP-1 co-agonist), and Retatrutide (triple GLP-1/GIP/glucagon agonist). What each receptor adds to the metabolic profile.
BPC-157 vs TB-500 — Pathway Comparison
BPC-157 and TB-500 are the two most-paired peptides in regenerative research, but they engage tissue repair through very different mechanisms. This comparison breaks down where the two compounds overlap, where they diverge, and why the combination is consistently used together rather than separately.